CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media Society of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management Select Drug-Drug Interactions With Direct Oral Anticoagulants Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost Mode of Death in Heart Failure With Preserved Ejection Fraction

Recommandation StatementDecember 10, 2018 [Epub ahead]

JOURNAL:Arterioscler Thromb Vasc Biol. Article Link

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

CB Newman and and on behalf of the American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Keywords: statin; ASCVD; risk; side effects; benefits

FULL TEXT PDF